Abstract:BACKGROUND:Prostate cancer (PCa) is one of the most frequent tumors and leading cause of cancer deaths among males worldwide. The majority of deaths are due to recurrence and subsequent development of the metastatic cancer. Although loss or dislocalization of polarity proteins has been implicated in embryogenesis deficiency and tumorigenesis, association of polarity protein expression levels with tumor metastasis remains unclear.METHODS:Bioinformatics, qRT-PCR, western blot and immunohistochemical (IHC) analyses were used to examine expression of Par3, a key component of polarity-associated partitioning defective (PAR) complex, in primary and metastatic clinical PCa samples. Loss-of-function and gain-of-function studies in vitro and in vivo were performed to determine the functions of Par3 during metastasis of PCa. Co-immunoprecipitation (co-IP), western blot, immunofluorescence (IF), chromatin immunoprecipitation (ChIP) and qRT-PCR analyses were conducted to investigate the underlying mechanism for the function of Par3 on PCa metastasis.RESULTS:In this study, we found that elevated expression of Par3 is positively associated with PCa metastasis. Knockdown of Par3 inhibits PCa cell migration and invasion in vitro and tumor metastasis in vivo, whereas overexpression of Par3 yields the opposite results. Mechanistically, Par3 suppresses phosphorylation of LATS to inactivate the Hippo pathway and enhances nuclear translocation of YAP by sequestrating KIBRA from the KIBRA/Merlin/FRMD6 complex and forming a Par3/aPKC/KIBRA complex. Stable knockdown of Par3 leads to restoration of the KIBRA/Merlin/FRMD6 complex and activation of the Hippo pathway, and then results in an inhibition on YAP nuclear translocation. In addition, in conjunction with the TEA domain (TEAD) transcription factor family, intranuclear YAP promotes the transcription of several pro-metastatic genes such as the matrix metalloproteinase (MMP) family, Zeb1, Snail1 and Twist1. Moreover, knockdown of Par3 downregulates expression of these pro-metastatic genes.CONCLUSIONS:Our findings indicate that elevated expression of Par3 promotes PCa metastasis via KIBRA sequestration-mediated inactivation of the Hippo pathway to upregulate expression of pro-metastatic genes. Downregulation of Par3 expression may serve as a potential treatment approach for PCa metastasis by activating the Hippo pathway.

PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer

PARD 3 Induces TAZ Activation and Cell Growth by Promoting LATS 1 and PP 1 Interaction

Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF‐κB signaling

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Loss of Par3 Promotes Prostatic Tumorigenesis by Enhancing Cell Growth and Changing Cell Division Modes.

MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial–mesenchymal transition in anaplastic thyroid cancer cells

PTPN3 Acts As a Tumor Suppressor and Boosts TGF-β Signaling Independent of Its Phosphatase Activity.

Loss of polarity protein Par3 is mediated by transcription factor Sp1 in breast cancer

Pseudogene PDIA3P1 Promotes Cell Proliferation, Migration and Invasion, and Suppresses Apoptosis in Hepatocellular Carcinoma by Regulating the P53 Pathway.

PRAD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3

Elevated Expression of Par3 Promotes Prostate Cancer Metastasis by Forming a Par3/aPKC/KIBRA Complex and Inactivating the Hippo Pathway

The polarity protein Par3 coordinates positively self-renewal and negatively invasiveness in glioblastoma

Loss of Polarity Protein Par3, Via Transcription Factor Snail, Promotes Bladder Cancer Metastasis.

Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway

Overexpression of transcription factor 3 drives hepatocarcinoma development by enhancing cell proliferation via activating Wnt signaling pathway

Hpcl3s Promotes Hepatocellular Carcinoma Metastasis by Activating Β-Catenin Signaling.

PRL-3 Facilitates Hepatocellular Carcinoma Progression by Co-Amplifying with and Activating FAK

STRN3 Promotes Tumour Growth in Hepatocellular Carcinoma by Inhibiting the Hippo Pathway.

circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway

P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR

PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF‐β Receptor 1